Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine

This study has been completed.
KuDOS Pharmaceuticals Limited
Information provided by:
AstraZeneca Identifier:
First received: August 13, 2007
Last updated: May 14, 2009
Last verified: May 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2009
  Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)